Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06543368 · ClinicalTrials.gov registry record · NA
Low-Cost Platelet-Rich Plasma for Hemarthropathy
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT06543368 is a NA study that has completed, run by University of Utah. The registered enrollment target is 14 participants.
The verdict
NCT06543368, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
Orthopedic complications can be injuries or diseases that affect the bones, muscles, and joints. Hemarthropathy is due to bleeding disorders, most commonly hemophilia, and can result in severe issues related to chronic amounts of blood in the body's joints. This causes swelling, pain, and loss of joint function. A serious barrier to treating many patients with bleeding disorders creates higher health risks and costs. Platelet-rich plasma (PRP) injection is a method that can reduce the cost of care while still offering a similar standard of care for patients. This study intends to show that low-cost PRP can be done safely in patients with bleeding disorders, without the need for expensive equipment, while monitoring patient treatment results. Study participants will receive injections for joint conditions. Being in the study requires attending 1 to 2 in-person visits at the study clinic. Participants will also complete surveys using email, text messages, in person, and/or on the phone. Participation lasts about 6 months.
Interventions
- BIOLOGICAL Intra articular PRP Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2024-07-23 |
| Est. Completion | 2025-05-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06543368
The ClinicalTrials.gov registry entry for NCT06543368 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intra articular PRP Injection is the first listed.
NCT06543368 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06543368 about?
NCT06543368 is a clinical study titled "Low-Cost Platelet-Rich Plasma for Hemarthropathy". Orthopedic complications can be injuries or diseases that affect the bones, muscles, and joints. Hemarthropathy is due to bleeding disorders, most commonly hemophilia, and can result in severe issues related to chronic amounts of blood in the body's joints. This causes swelling, pain, and loss of jo...
What is the current status of trial NCT06543368?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2024-07-23. Estimated completion is 2025-05-05.
What interventions are being tested in trial NCT06543368?
The interventions under investigation include: Intra articular PRP Injection (BIOLOGICAL).
Who is sponsoring clinical trial NCT06543368?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.